Nsaid-induced Gastric Ulcers

• FDA approval · 2025-04-15
  FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)

  FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, enabling its marketing as a generic drug in …

• FDA approval · 2022-10-06
  FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (Ajanta Pharma USA Inc.)

  FDA approved Ajanta Pharma USA Inc.'s Naproxen and Esomeprazole Magnesium as an Original Application (ANDA213699), providing a generic versi…

• FDA approval · 2022-05-18
  FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Novadoz Pharmaceuticals LLC)

  The FDA approved Pantoprazole sodium from Novadoz Pharmaceuticals LLC under an Original Application (ANDA216171), adding a generic pantopraz…

• FDA approval · 2018-07-20
  FDA Approved: OMEPRAZOLE — Original Application (INNOVUS PHARMACEUTICALS, INC.)

  FDA approved a generic version of omeprazole (omeprazole and omeprazole magnesium) under ANDA210593 from Innovus Pharmaceuticals.

• CLINICAL_TRIALS trial_result · 2009-03-13
  Clinical Trial Update: Prevention of Gastric Ulcers [Phase 3]

  A Phase 3 trial, sponsored by AstraZeneca, evaluating prevention of NSAID-associated gastric ulcers has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.